Insider Trading & Ownership - Gupta Rishi

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gupta Rishi
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-16
Sale
2024-05-20
5:03 pm
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
1,033,300$22.14$22,877,2627,663,349
(Indirect)
View
2023-07-20
Purchase
2023-07-24
4:40 pm
Turnstone Biologics Corp.TSBXGupta Rishi
Director
10% Owner
416,666$12$4,999,9923,099,265
(Indirect)
View
2023-05-11
Sale
2023-05-15
6:06 pm
Verona Pharma plcVRNAGupta Rishi
Director
482,913$20.58$9,938,1323,777,778
(Indirect)
View
2022-12-22
Sale
2022-12-27
5:32 pm
Verona Pharma plcVRNAGupta Rishi
Director
6,139,864$22.15$136,000,85534,085,528
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-03
Option Award
2024-07-02
4:45 pm
N/A
2034-06-02
Turnstone Biologics Corp.TSBXGupta Rishi
Director
10% Owner
12,770$012,770
(Direct)
View
2024-02-13
Option Award(A)
2024-02-20
7:30 pm
N/A
2034-02-13
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
23,364$023,364
(Direct)
View
2024-02-13
Option Award
2024-02-15
8:50 pm
N/A
2034-02-12
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
16,835$016,835
(Direct)
View
2023-10-16
Option Award
2023-10-17
6:40 pm
N/A
2033-10-15
Turnstone Biologics Corp.TSBXGupta Rishi
Director
10% Owner
25,540$025,540
(Direct)
View
2023-07-20
Conversion
2023-07-24
4:40 pm
N/A
N/A
Turnstone Biologics Corp.TSBXGupta Rishi
Director
10% Owner
5,365,198$03,099,265
(Indirect)
View

Ownership
2023-07-20
9:51 pm
N/A
N/A
Turnstone Biologics Corp.TSBXGupta Rishi
Director
10% Owner
0$02,682,599
(Indirect)
View
2023-05-17
Exercise
2023-05-19
4:12 pm
N/A
2032-06-01
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
2,125$08,951,463
(Indirect)
View
2023-05-17
Exercise
2023-05-19
4:12 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
2,125$4.288,951,463
(Indirect)
View
2023-04-28
Option Award
2023-04-28
4:20 pm
N/A
2033-04-27
Verona Pharma plcVRNAGupta Rishi
Director
96,000$096,000
(Direct)
View
2023-02-23
Option Award
2023-04-06
8:18 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
27,567$027,567
(Direct)
View
2023-02-23
Option Award
2023-02-27
9:53 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
7,899,572$0288,114
(Indirect)
View
2022-04-28
Option Award
2022-04-29
4:45 pm
N/A
2032-04-27
Verona Pharma plcVRNAGupta Rishi
Director
200,000$0200,000
(Direct)
View
2021-08-09
Option Award
2021-08-10
4:46 pm
N/A
2031-08-08
Verona Pharma plcVRNAGupta Rishi
Director
64,000$064,000
(Direct)
View

Ownership
2021-01-05
7:22 pm
N/A
N/A
Verona Pharma plcVRNAGupta Rishi
Director
10% Owner
0$042,093,331
(Indirect)
View

Ownership
2021-01-04
8:20 pm
N/A
2030-09-24
Verona Pharma plcVRNAGupta Rishi
Director
0$0185,600
(Direct)
View
(A) Indicate amendment filing.